Ethyl 2-(2-((5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate

Catalog No. :
ACASWT861
CAS No. :
332161-19-0
Molecular Formula :
C21H20BrN3O4S2
Molecular Weight :
522.45

IUPAC Name:ethyl 2-(2-((5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate

Ethyl 2-(2-((5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$272.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(2-((5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
IUPAC Nameethyl 2-(2-((5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
Molecular FormulaC21H20BrN3O4S2
Molecular Weight522.45
SMILESO=C(C1=C(NC(CSC2=NN=C(C3=CC=C(Br)C=C3)O2)=O)SC4=C1CCCC4)OCC
InChI KeyFZPLZBKOUFVGID-UHFFFAOYSA-N
Synonym2-{2-[5-(4-Bromo-phenyl)-[1,3,4]oxadiazol-2-ylsulfanyl]-acetylamino}-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid ethyl ester
CAS No.332161-19-0

Synthetic Route by SureRoute

1. ACASWT861 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMLHN341 route compound structure diagram
    ACMLHN3414506-71-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACASWT861 route product structure diagram
    ACASWT861332161-19-0
Inquiry

2. ACASWT861 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMLHN341 route compound structure diagram
    ACMLHN3414506-71-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACASWT861 route product structure diagram
    ACASWT861332161-19-0
Inquiry

Comments (0)